Saltar al contenido
Merck

mRNA and protein levels for GABAAalpha4, alpha5, beta1 and GABABR1 receptors are altered in brains from subjects with autism.

Journal of autism and developmental disorders (2010-01-13)
S Hossein Fatemi, Teri J Reutiman, Timothy D Folsom, Robert J Rooney, Diven H Patel, Paul D Thuras
RESUMEN

We have shown altered expression of gamma-aminobutyric acid A (GABA(A)) and gamma-aminobutyric acid B (GABA(B)) receptors in the brains of subjects with autism. In the current study, we sought to verify our western blotting data for GABBR1 via qRT-PCR and to expand our previous work to measure mRNA and protein levels of 3 GABA(A) subunits previously associated with autism (GABRalpha4; GABRalpha5; GABRbeta1). Three GABA receptor subunits demonstrated mRNA and protein level concordance in superior frontal cortex (GABRalpha4, GABRalpha5, GABRbeta1) and one demonstrated concordance in cerebellum (GABBetaR1). These results provide further evidence of impairment of GABAergic signaling in autism.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti-β-actina monoclonal antibody produced in mouse, clone AC-15, ascites fluid
Sigma-Aldrich
IgG anti-ratón (molécula completa)-Peroxidasa antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
IgG anti-conejo (molécula completa)-Peroxidasa antibody produced in goat, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Anticuerpo anti-receptor α4 del GABA A , CT, Chemicon®, from rabbit
Sigma-Aldrich
Anti-GABA A Receptor β 1 Antibody, Chemicon®, from rabbit